Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage XXXX .

@entity1 @entity1149 @entity2 @entity3 @entity204 @entity1349
PURPOSE: This study aimed to evaluate the prognostic significance of the modified Glasgow Prognostic Score (mGPS) in @entity1 with @entity1149 ( @entity1149 ) who received stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS: Data from 165 @entity1 who underwent SBRT for stage I @entity1149 with histologic confirmation from January 1999 to September 2010 were collected retrospectively. Factors, including age, performance status, histology, Charlson comorbidity index, mGPS, and recursive partitioning analysis (RPA) class based on sex and T stage, were evaluated with regard to @entity1349 ( @entity1349 ) using the Cox proportional hazards model. The impact of the mGPS on cause of @entity204 and failure patterns was also analyzed. RESULTS: The 3-year @entity1349 was 57.9%, with a median follow-up time of 3.5 years. A higher mGPS correlated significantly with poor @entity1349 (P<.001). The 3-year @entity1349 of lower mGPS @entity1 was 66.4%, whereas that of higher mGPS @entity1 was 44.5%. On multivariate analysis, mGPS and RPA class were significant factors for @entity1349 . A higher mGPS correlated significantly with @entity2 @entity204 (P=.019) and distant @entity3 (P=.013). CONCLUSIONS: The mGPS was a significant predictor of clinical outcomes for SBRT in @entity1149 @entity1 .
